Recent Updates
Recently added Catalysts
KEQU Positive Sentiment Score: 60/100

Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

Key Takeaway: Kewaunee Scientific Corporation will release its financial results for the fourth quarter and fiscal year ending April 30, 2026, on June 23, 2026. The company, a leader in laboratory and healthcare furniture, has expanded its portfolio with the acquisition of Nu Aire. The announcement highlights the company's commitment to transparency and growth, despite potential risks associated with forward-looking statements.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kewaunee Scientific is set to report its financial results, indicating transparency.
  • The company has a strong history since 1906 and a diverse product portfolio.
  • The acquisition of Nu Aire enhances Kewaunee's offerings in laboratory products.

CONCERNS & RISKS

  • Forward-looking statements carry inherent risks and uncertainties.
  • Potential disruptions from government mandates and supply chain issues.
  • Fluctuations in operating results may impact financial stability.

Full Press Release Details

STATESVILLE, N.C.,June 10, 2026/PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after the close of trading. This information will be available on the Company's websitewww.kewaunee.comafter the release.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, Spain, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.
Learn more at the companies' websites, located athttp://www.kewaunee.comandhttp://www.nuaire.com/.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website atwww.kewaunee.comand on the SEC website atwww.sec.gov.These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Donald T. Gardner III
704/871-3274
Contact:
Donald T. Gardner III
704/871-3274
SOURCE Kewaunee Scientific Corporation

21%

Frequently Asked Questions

When will Kewaunee Scientific report its financial results?

Kewaunee Scientific will report its financial results on June 23, 2026.

What is the significance of the Nu Aire acquisition?

The Nu Aire acquisition enhances Kewaunee's product offerings in laboratory equipment.

What risks are associated with Kewaunee's forward-looking statements?

Risks include supply chain disruptions, economic conditions, and fluctuating operating results.

Where can I find Kewaunee Scientific's financial reports?

Financial reports are available on Kewaunee's investor relations website and the SEC website.

Last updated: Jun 10, 2026